Under the direction of GIOSTAR Co-Founder Dr. Anand Srivastava, a patient was treated with a topical application of mesenchymal stem cells. Remarkably, the patient saw their psoriasis regress completely after only one month.
Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.
https://youtu.be/hhhKunFetX4 GIOSTAR Co-Founders Dr. Anand Srivastava and Deven Patel recently spoke with Dr. Amy Killen about the company’s ongoing research efforts related to coronavirus (COVID-19). Dr. Anand explains in great detail the mechanisms underlying the disease, including cytokine storms and the potential immunomodulatory benefits of […]
https://youtu.be/fMVaMdQCgns Dr. Anand Srivastava, Chairman and Co-Founder of GIOSTAR, speaks with Evan DeMarco, Janna Breslin, and the GIOSTAR Mexico team about the potential for stem cells in combatting COVID-19. Related Resources GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem […]
https://youtu.be/UglUrxTyEwI Since its outbreak, coronavirus (COVID-19) has cast an unprecedented impact that has reverberated throughout the world. Scientists, government officials, and doctors have searched frantically for a remedy, to help contain further disruption. In this video, GIOSTAR Co-Founder and Chairman Dr. Anand Srivastava reports on a […]
For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.
Under the direction of Dr. Srivastava, the patient was treated with Mesenchymal Stem Cell Conditioned Media (MSC-CM), which was applied topically to affected areas daily. Remarkably, after only one month, the patient saw their psoriasis regress completely.
Dr. Gellis continues his insightful discussion with Dr. Anand Srivastava about the ever-evolving landscape of regenerative medicine.
This installment of GIOTalk features a helpful overview of Dr. Anand Srivastava’s ground-breaking discoveries in the field of stem cell research, along with his views on the future of regenerative medicine.
IMPORTANT! All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.
